Funds · DRUG

Who owns DRUG?

Institutional ownership of Bright Minds Biosciences Inc. from Form 13F, Q2 2026

100 institutional managers reported holding Bright Minds Biosciences Inc. (DRUG) in Form 13F filings for Q2 2026, with 9,311,244 shares worth $654M. The largest reported holder was Jupiter Topco LLC. Managers that filed both quarters added a net 58,121 shares (+0.7%). 19 opened new positions and 11 sold out.

Funds holding
100
Value held
$654M
New / sold out
19 / 11
Net shares, same filers
+0.7%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of DRUG

FundValueShare of 13F holdingsSharesMove
Jupiter Topco LLC$94.8M14.5%1,349,107First report
Cormorant Asset Management, LP$63.2M9.7%900,000Trimmed
BlackRock, Inc.$48.2M7.4%686,184Added
Vivo Capital, LLC$39.1M6.0%557,172Unchanged
Vestal Point Capital, LP$38.3M5.9%545,000Added
Braidwell LP$34.0M5.2%483,822Trimmed
Driehaus Capital Management LLC$30.4M4.7%433,377Added
Balyasny Asset Management L.P.$24.2M3.7%345,053Added
Adage Capital Partners GP, L.l.c.$23.5M3.6%335,000Trimmed
Point72 Asset Management, L.P.$23.0M3.5%327,416New
Deerfield Management Company, L.p.$19.9M3.0%283,000Unchanged
Ra Capital Management, L.p.$18.6M2.8%265,000Unchanged
Parkman Healthcare Partners LLC$14.4M2.2%205,053Added
MPM Bioimpact LLC$14.2M2.2%202,114Trimmed
Wellington Management Group LLP$12.0M1.8%171,315Added
Goldman Sachs Group Inc$9.4M1.4%133,689Added
Eventide Asset Management, LLC$9.1M1.4%130,013Unchanged
State Street Corp$8.6M1.3%122,178Added
Seven Grand Managers, LLC$8.4M1.3%120,000Unchanged
Great Point Partners LLC$7.7M1.2%109,603Trimmed
Geode Capital Management, LLC$7.3M1.1%104,146Added
Orbimed Advisors LLC$6.5M1.0%93,000Added
Acuta Capital Partners, LLC$6.5M1.0%92,745Trimmed
Ikarian Capital, LLC$6.2M1.0%88,951Trimmed
Vanguard Portfolio Management LLC$5.6M0.9%80,060Added

Share of 13F holdings is each fund's shares as a share of the 9,311,244 DRUG shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $88.4M and sold $85.5M; 47 added and 17 trimmed.

Schedule 13D and 13G filings on DRUG

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about DRUG ownership

Who owns DRUG stock?
100 institutional investment managers reported DRUG positions in their Form 13F filings for Q2 2026, holding 9,311,244 shares worth $654M in total. Jupiter Topco LLC reported the largest position.
Are funds buying or selling DRUG?
In Q2 2026, 19 managers opened new DRUG positions, 47 added, 17 trimmed and 11 sold out. Managers that filed in both quarters added a net 58,121 shares.
How current is this DRUG institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to DRUG by CUSIP. Options are left out. DRUG news and filings · DRUG insider trades · Top funds